New registry sheds light on rare overgrowth diseases
NCT ID NCT05563831
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study created a French national registry for people with rare overgrowth syndromes caused by PIK3CA gene mutations. Researchers collected medical and genetic information from 28 patients to better understand these conditions and estimate how many people are affected. The goal was to improve knowledge, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOVES SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Translational medicine and Targeted therapies unit, Hôpital Necker Enfants Malades
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new questionnaire give patients a stronger voice in vascular malformation care?
- Can a cancer drug shrink birthmarks? bleomycin injections put to the test
- Electric pulses may boost a drug's power against painful vascular malformations
- Electric shock therapy may shrink blood vessel birthmarks
- Small study examines risks of injection treatment for Children's facial vein blemishes
- Electric shocks boost drug to shrink blood vessel tangles